Ameriprise’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Sell |
35,851
-35,187
| -50% | -$129K | ﹤0.01% | 3829 |
|
|
2025
Q1 | $307K | Sell |
71,038
-57
| -0.1% | -$246 | ﹤0.01% | 3638 |
|
|
2024
Q4 | $228K | Sell |
71,095
-61,072
| -46% | -$195K | ﹤0.01% | 3796 |
|
|
2024
Q3 | $378K | Sell |
132,167
-300
| -0.2% | -$858 | ﹤0.01% | 3567 |
|
|
2024
Q2 | $371K | Sell |
132,467
-223,984
| -63% | -$627K | ﹤0.01% | 3525 |
|
|
2024
Q1 | $1.01M | Buy |
356,451
+13,976
| +4% | +$39.7K | ﹤0.01% | 3161 |
|
|
2023
Q4 | $1.4M | Buy |
342,475
+9,707
| +3% | +$39.7K | ﹤0.01% | 3050 |
|
|
2023
Q3 | $1.06M | Sell |
332,768
-89,539
| -21% | -$285K | ﹤0.01% | 3115 |
|
|
2023
Q2 | $1.4M | Sell |
422,307
-65,452
| -13% | -$217K | ﹤0.01% | 3034 |
|
|
2023
Q1 | $1.04M | Sell |
487,759
-35,871
| -7% | -$76.4K | ﹤0.01% | 3136 |
|
|
2022
Q4 | $1.41M | Sell |
523,630
-11,023
| -2% | -$29.6K | ﹤0.01% | 2967 |
|
|
2022
Q3 | $1.73M | Buy |
534,653
+80,639
| +18% | +$261K | ﹤0.01% | 2844 |
|
|
2022
Q2 | $2.22M | Sell |
454,014
-4,288
| -0.9% | -$20.9K | ﹤0.01% | 2766 |
|
|
2022
Q1 | $3.49M | Buy |
458,302
+63,111
| +16% | +$481K | ﹤0.01% | 2649 |
|
|
2021
Q4 | $3.65M | Buy |
395,191
+115,899
| +41% | +$1.07M | ﹤0.01% | 2676 |
|
|
2021
Q3 | $3.98M | Buy |
279,292
+62,502
| +29% | +$890K | ﹤0.01% | 2542 |
|
|
2021
Q2 | $3.6M | Buy |
+216,790
| New | +$3.6M | ﹤0.01% | 2663 |
|